Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
The DOI matches its Crossref record; 413 of the 418 references it cites were found in a registry or an index.
Abstract
In both type 1 and type 2 diabetes, the late diabetic complications in nerve, vascular endothelium, and kidney arise from chronic elevations of glucose and possibly other metabolites including free fatty acids (FFA). Recent evidence suggests that common stress-activated signaling pathways such as nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases underlie the development of these late diabetic complications. In addition, in type 2 diabetes, there is evidence that the activation of these same stress pathways by glucose and possibly FFA leads to both insulin resistance and impaired insulin secretion. Thus, we propose a unifying hypothesis whereby hyperglycemia and FFA-induced activation of the nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases stress pathways, along with the activation of the advanced glycosylation end-products/receptor for advanced glycosylation end-products, protein kinase C, and sorbitol stress pathways, plays a key role in causing late complications in type 1 and type 2 diabetes, along with insulin resistance and impaired insulin secretion in type 2 diabetes. Studies with antioxidants such as vitamin E, α-lipoic acid, and N-acetylcysteine suggest that new strategies may become available to treat these conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rather, excessive ROS emission may lead to the serine phosphorylation of IRS proteins, thus inhibiting insulin signaling (98).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [98]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Research works printed but not linked: 4
- Yuan, 2000, Salicylate inhibition of IKKβ (IκB kinase) reverses insulin resistance in Zucker (fa/fa) rats, Diabetes, 49, A292
- Hundal, 2001, Potential for a novel class of insulin sensitizing agents by inhibition of IKKβ activity, Diabetes, 50, A117
- Liang, 1991, Glucose at physiological levels induces glucokinase, glucose usage, and insulin secretion in cultures pancreatic islets, Diabetes, 40, 177A
- Grodsky, 1968, Factors influencing different rates of insulin release, Acta Diabetol Lat, 1, 140
Cited by
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
“insulin function in diabetic subjects (61, 62).”
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis
Sinha, K., Das, J., Pal, P. B., & Sil, P. C. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1034-4 · Cited by 1,625
Metadata
- Authors
- Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M.
- Affiliations
- Medical Research Institute (J.L.E.), San Bruno, California 94066
- University of California, San Francisco (US)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2002-10-01
- Volume
- 23
- Issue
- 5
- Pages
- 599-622
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2083990676
- Cited by
- 2,232
- References
- 418
- Citations by year
- 2026: 49 · 2025: 57 · 2024: 67 · 2023: 65 · 2022: 77 · 2021: 83 · 2020: 83 · 2019: 98 · 2018: 95 · 2017: 104 · 2016: 105 · 2015: 143 · 2014: 138 · 2013: 135 · 2012: 146
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- type 2 diabetes, type 1 diabetes, oxidative stress, nuclear factor-kappaB, p38 MAPK, c-Jun N-terminal kinase, advanced glycation end products, protein kinase C, polyol pathway, hyperglycemia, free fatty acids, insulin resistance, impaired insulin secretion, diabetes complications, antioxidants, vitamin E, alpha-lipoic acid, N-acetylcysteine
- MeSH terms
- Animals, Antioxidants, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Insulin Resistance, Islets of Langerhans, Lymphokines, Signal Transduction, Endothelial Growth Factors, NF-kappa B, Reactive Oxygen Species, Oxidative Stress, Mitogen-Activated Protein Kinases, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.